HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Urology29 papers

Clear cell adenocarcinoma

Last edited: 4/15/2026

Overview

Clear cell adenocarcinoma of the urethra is a rare malignancy predominantly affecting females, characterized by its distinct histological features 1.

Diagnosis

  • Histological confirmation required showing clear cell morphology 1.
  • Imaging studies (e.g., MRI, CT) to assess local extent and potential metastasis 1.
  • Biopsy essential for definitive diagnosis and grading 1.

    • Management

  • Surgical resection (e.g., wide local excision, urethrectomy) is the primary treatment modality 1.
  • Adjuvant therapy (chemotherapy, radiation) considered based on stage and risk factors, though specific regimens are not detailed in the abstract 1.
  • Follow-up includes regular imaging and clinical assessments to monitor recurrence 1.

    • Special Populations

  • No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities 1.

    • Key Recommendations

  • Definitive diagnosis necessitates histological examination 1 (Evidence: Weak).
  • Surgical intervention tailored to extent of disease is crucial 1 (Evidence: Weak).
  • Adjuvant treatments should be individualized based on clinical staging and risk stratification 1 (Evidence: Expert opinion).

    • References

    1 Assimos DG, O'Conor VJ. Clear cell adenocarcinoma of the urethra. The Journal of urology 1984. link50487-5)

    Original source

    1. [1]
      Clear cell adenocarcinoma of the urethra. — Assimos DG, O'Conor VJ The Journal of urology (1984)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG